Cost-effective analyses in Breast Cancer Research and Treatment Marc E. LippmanStephen EthierDaniel F. Hayes EditorialNotes 18 May 2009 Pages: 221 - 222
Terpenoids and breast cancer chemoprevention Thangaiyan RabiAnupam Bishayee Review 19 July 2008 Pages: 223 - 239
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers Jan P. A. BaakEinar GudlaugssonAxel zur Hausen Review 30 July 2008 Pages: 241 - 254
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review Jennifer FlemmingYolanda MadarnasJacob A. Franek Review 06 August 2008 Pages: 255 - 268
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model Jiangbing ZhouHao ZhangYing Zhang Preclinical Study 28 May 2008 Pages: 269 - 277
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones Shirley M. PotterRoisin M. DwyerMichael J. Kerin Preclinical Study 04 June 2008 Pages: 279 - 287
The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance Matthew J. SikoraKevin E. CorderoJames M. Rae Preclinical Study 04 June 2008 Pages: 289 - 296
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells Marilena LanzinoCecilia GarofaloDiego Sisci Preclinical Study 04 June 2008 Pages: 297 - 306
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers Amanda B. SpurdleAndrew J. DeansGeorgia Chenevix-Trench Preclinical Study 10 June 2008 Pages: 307 - 313
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families Thomas v. O. HansenLars JønsonFinn C. Nielsen Preclinical Study 12 June 2008 Pages: 315 - 323
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients Wen-Jin YinJin-Song LuZhi-Ming Shao Preclinical Study 18 June 2008 Pages: 325 - 333
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer Hye-Suk HanJungsil RoSeok Won Kim Clinical Trial 28 May 2008 Pages: 335 - 342
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy Qifeng YangMeena S. MoranBruce G. Haffty Clinical Trial 31 May 2008 Pages: 343 - 348
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors Olivier BrouckaertSaskia PintensPatrick Neven Clinical Trial 16 July 2008 Pages: 349 - 358
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients T. ByrskiT. HuzarskiS. A. Narod Clinical Trial Open access 23 July 2008 Pages: 359 - 363
Psychological impact of recall in high-risk breast MRI screening Suzanne M. O’NeillWendy S. RubinsteinRobert R. Edelman Clinical Trial 26 July 2008 Pages: 365 - 371
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer Rupert BartschBrigitte Mlineritschon behalf of the Austrian Fulvestrant Registry Clinical Trial 26 July 2008 Pages: 373 - 380
Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? Catharina E. JacobiGeertruida H. de BockChristi J. van Asperen Epidemiology 30 May 2008 Pages: 381 - 390
CYP2C19*17 is associated with decreased breast cancer risk Christina JustenhovenUte HamannHiltrud Brauch Epidemiology 03 June 2008 Pages: 391 - 396
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer Xinran XuMarilie D. GammonJia Chen Epidemiology 03 June 2008 Pages: 397 - 404
High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations Inmaculada de JuanEva EstebanPascual Bolufer Epidemiology 05 June 2008 Pages: 405 - 414
A retrospective study of quality of life in a community sample of patients with early stage breast cancer Mark S. WalkerLee S. SchwartzbergBarry V. Fortner Epidemiology 17 April 2009 Pages: 415 - 422
Pattern of metastatic spread in triple-negative breast cancer Rebecca DentWedad M. HannaSteven A. Narod Epidemiology 10 June 2008 Pages: 423 - 428
The rising incidence of male breast cancer Valerie SpeirsAbeer M. Shaaban Letter to the Editor 14 May 2008 Pages: 429 - 430
Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer Ragip ÇamAydan ErogluNejat Akar Letter to the Editor 24 May 2008 Pages: 431 - 432
The sensitivity of BRCA1 mutation carriers to ionising radiation: questions of methodology Magdalena ChechlinskaRadoslawa Nowak Letter to the Editor 27 May 2008 Pages: 433 - 433
Link between insulin and metabolic disorders in cancer: does leptin play a key role? Noemi MalandrinoLorenzo LeggioEsmeralda Capristo Letter to the Editor 17 June 2008 Pages: 435 - 436
